CME Group (NASDAQ:CME) Given New $226.00 Price Target at Deutsche Bank Aktiengesellschaft

CME Group (NASDAQ:CME - Get Free Report) had its price target cut by equities researchers at Deutsche Bank Aktiengesellschaft from $227.00 to $226.00 in a research report issued on Monday,Benzinga reports. The firm presently has a "hold" rating on the financial services provider's stock. Deutsche Bank Aktiengesellschaft's price objective would indicate a potential upside of 0.03% from the company's previous close.

A number of other equities research analysts have also weighed in on CME. The Goldman Sachs Group lifted their price objective on CME Group from $195.00 to $198.00 and gave the stock a "sell" rating in a research report on Thursday, October 3rd. Citigroup lifted their price objective on CME Group from $250.00 to $255.00 and gave the stock a "buy" rating in a research report on Thursday, October 24th. Morgan Stanley lifted their price objective on CME Group from $210.00 to $233.00 and gave the stock an "equal weight" rating in a research report on Thursday, October 17th. Redburn Atlantic lowered CME Group from a "buy" rating to a "neutral" rating and set a $244.00 price objective on the stock. in a research report on Tuesday, October 8th. Finally, Keefe, Bruyette & Woods lifted their price objective on CME Group from $212.00 to $213.00 and gave the stock a "market perform" rating in a research report on Thursday, July 25th. Four equities research analysts have rated the stock with a sell rating, seven have assigned a hold rating and four have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has a consensus rating of "Hold" and an average price target of $224.47.

CME Group Price Performance

Shares of CME Group stock traded up $0.27 during trading on Monday, hitting $225.93. 1,148,465 shares of the stock traded hands, compared to its average volume of 1,915,664. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.09. The stock has a market cap of $81.36 billion, a price-to-earnings ratio of 23.80, a PEG ratio of 5.68 and a beta of 0.55. The firm's fifty day moving average is $221.72 and its 200-day moving average is $209.84. CME Group has a 52 week low of $190.70 and a 52 week high of $230.36.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.65 by $0.03. CME Group had a return on equity of 13.39% and a net margin of 57.34%. The business had revenue of $1.58 billion for the quarter, compared to analyst estimates of $1.59 billion. During the same period last year, the company earned $2.25 EPS. CME Group's revenue for the quarter was up 18.4% compared to the same quarter last year. Research analysts expect that CME Group will post 10.23 EPS for the current fiscal year.

Insider Activity

In related news, Director Martin J. Gepsman sold 400 shares of the stock in a transaction dated Monday, November 4th. The stock was sold at an average price of $222.92, for a total transaction of $89,168.00. Following the completion of the sale, the director now owns 25,067 shares in the company, valued at approximately $5,587,935.64. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. In other news, Director Bryan T. Durkin sold 7,593 shares of the firm's stock in a transaction that occurred on Friday, August 30th. The stock was sold at an average price of $214.59, for a total value of $1,629,381.87. Following the completion of the sale, the director now directly owns 55,607 shares of the company's stock, valued at $11,932,706.13. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Martin J. Gepsman sold 400 shares of the firm's stock in a transaction that occurred on Monday, November 4th. The stock was sold at an average price of $222.92, for a total value of $89,168.00. Following the sale, the director now directly owns 25,067 shares of the company's stock, valued at $5,587,935.64. This represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,621 shares of company stock worth $3,441,063 in the last three months. Company insiders own 0.30% of the company's stock.

Institutional Investors Weigh In On CME Group

Institutional investors and hedge funds have recently bought and sold shares of the company. Harbor Capital Advisors Inc. lifted its position in CME Group by 0.6% during the 3rd quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider's stock worth $1,723,000 after acquiring an additional 45 shares during the period. CVA Family Office LLC lifted its holdings in shares of CME Group by 11.8% in the 3rd quarter. CVA Family Office LLC now owns 436 shares of the financial services provider's stock valued at $96,000 after buying an additional 46 shares during the period. Lester Murray Antman dba SimplyRich lifted its holdings in shares of CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider's stock valued at $1,507,000 after buying an additional 50 shares during the period. Zions Bancorporation N.A. lifted its holdings in shares of CME Group by 3.7% in the 3rd quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider's stock valued at $338,000 after buying an additional 54 shares during the period. Finally, Quent Capital LLC lifted its holdings in shares of CME Group by 10.2% in the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider's stock valued at $131,000 after buying an additional 55 shares during the period. 87.75% of the stock is owned by institutional investors.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.